Skip to Main Content

Paper Details

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.
Blood Cancer J
1
2022
Author NameAffiliation
Janet A DunnWarwick Clinical Trials Unit, University of Warwick
  • 1 - 1

Datasets

Release 1.2